Invention Grant
- Patent Title: Degron fusion constructs and methods for controlling protein production
-
Application No.: US15737712Application Date: 2016-06-28
-
Publication No.: US10550379B2Publication Date: 2020-02-04
- Inventor: Michael Z. Lin , Hokyung Chung , Conor Jacobs
- Applicant: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
- Applicant Address: US CA Stanford
- Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee Address: US CA Stanford
- Agency: Bozicevic, Field & Francis LLP
- Agent Brian E. Davy
- International Application: PCT/US2016/039792 WO 20160628
- International Announcement: WO2017/004022 WO 20170105
- Main IPC: C12N9/50
- IPC: C12N9/50 ; C12N15/86 ; G01N33/68

Abstract:
Engineered fusion proteins comprising a self-excising degron for controlling protein production are disclosed. In particular, the inventors have constructed fusion proteins comprising a degron connected to a protein of interest through a cleavable linker comprising a hepatitis C virus (HCV) protease site. The degron can be removed from the protein of interest by a czs-encoded HCV protease such that the protein of interest can be produced with minimal structural modification. Clinically available HCV protease inhibitors can be used to block protease cleavage such that the degron is retained after inhibitor addition on subsequently synthesized protein copies. The degron when attached causes rapid degradation of the linked protein. Such fusions of a degron to a protein of interest will be especially useful when control over protein production with minimal structural modification is desired.
Public/Granted literature
- US20180179509A1 DEGRON FUSION CONSTRUCTS AND METHODS FOR CONTROLLING PROTEIN PRODUCTION Public/Granted day:2018-06-28
Information query